Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection
Effective treatments for coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed. Dexamethasone has been shown to confer survival benefits to certain groups of hospitalized patients, but whether glucocorticoids such as dexamethas...
Saved in:
| Main Authors: | Zi-Wei Ye, Shuofeng Yuan, Jasper Fuk-Woo Chan, Anna Jinxia Zhang, Ching-Yun Yu, Chon Phin Ong, Dong Yang, Chris Chun-Yiu Chan, Kaiming Tang, Jianli Cao, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Jian-Piao Cai, Hin Chu, Kwok-Yung Yuen, Dong-Yan Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-01-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1885998 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters
by: Megan Neary, et al.
Published: (2024-11-01) -
Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study
by: Nithish Sattoju, et al.
Published: (2023-07-01) -
Immunological Effects of Remdesivir on Colon Cancer Cell Line
by: Alaa Hameed, et al.
Published: (2025-04-01) -
Synthesis of Radioisotope 14C Labelled Remdesivir
by: Zhi-yang YU, et al.
Published: (2025-02-01) -
Efficacy and safety of remdesivir and favipiravir in COVID-19 patients – A systematic review and meta-analysis
by: Piyush Vatsha, et al.
Published: (2025-05-01)